Form 4 for LAB STANDARD BIOTOOLS INC.
Accepted 2025-06-24 00:00:00 ET · period of report 2025-06-20 · accession 0000950170-25-089641 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2025-06-24 | 2025-06-20 | LAB | Witney Frank | Dir | A - Grant | $0.00 | +94.6K | 210.9K | +81% | $0 |
| D | 2025-06-24 | 2025-06-20 | LAB | Witney Frank | Dir | A - Grant | $0.00 | +125.7K | 125.7K | New | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2025-06-20 | A | A | 94,592 | $0.00 | 210,862 | D | — | — | (F1) Represents Restricted Stock Units ("RSUs") that vest in full on the earlier to occur of June 20, 2026 and one day prior to the date of the Company's next annual meeting of stockholders, subject to the Reporting Person's continued service through the applicable vesting date. Each RSU represents the right to receive one share of common stock upon vesting. |
| 2 | Derivative | Stock Option (Right to buy) | 2025-06-20 | A | A | 125,660 | $0.00 | 125,660 | D | $1.05 · — to 2035-06-20 | 125,660 Common Stock | (F3) The Option becomes exercisable in twelve equal monthly installments beginning on July 20, 2025, subject to the Reporting Person's continued service through the applicable vesting date. |